1. The subject of this order is the gradual delivery of medicines for the Oncology Center of the Maria Skłodowska-Curie Institute in Gliwice.
2. Description of the subject of the contract and the conditions of the contract are included in the forms:
a) Assortment and price specification - Annexes 2.1 to 2.3 to the ToR
b) Contract template - Annex 4 to the ToR
3. If the medicine in the international name is on the reimbursement list, then the medicine offered must appear on it and its price must be equal to or lower than the funding limits.
4. The Awarding Entity does not anticipate concluding a framework agreement, establishing a dynamic purchasing system, electronic auction or supplementary orders.
5. Detailed information on these proceedings is contained in the ToR.
Task # 1 - Alectinib.
Description of the subject of the contract and the conditions of the contract are included in the forms:
a) Assortment and price specification - Annexes 2.1 to 2.1 to the ToR
b) Contract template - Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. for marketing in the Republic of Poland for the offered medicinal product and to present them at the request of the Purchaser.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task # 2 - Palbociclib.
Description of the subject of the contract and the conditions of the contract are included in the forms:
a) Assortment and price specification - Annexes 2.1 to 2.2 to the ToR
b) Contract template - Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. for marketing in the Republic of Poland for the offered medicinal product and to present them at the request of the Purchaser.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.
Task # 3 - Ribociclib.
Description of the subject of the contract and the conditions of the contract are included in the forms:
a) Assortment and price specification - Annexes 2.1 to 2.3 to the ToR
b) Contract template - Annex 4 to the ToR.
The medicinal products subject to this order have established quality standards. These standards were established for each medicinal product during its registration and are the same for the chemical substances they contain. Medicinal products for their use do not require any distinctive elements within the individual substances. In addition, every medicinal product traded on the territory of the Republic of Poland must be registered.
Medicinal products that are the subject of the contract must be approved for use in Poland in accordance with the provisions of the Pharmaceutical Law of September 6, 2001 (i.e. for marketing in the Republic of Poland for the offered medicinal product and to present them at the request of the Purchaser.
Preparations with the same chemical name, but with different doses, must be offered from one manufacturer, so that in practice it is possible to combine doses.
If no dose size is given, the customer reserves the right to place orders for all doses produced by a given manufacturer.
If the medicinal product in the international name is on the reimbursement list, then the offered medicinal product must be on it and its price must be equal to or lower than the funding limits.
The medicinal products on offer must have a validity period of at least 12 months from the date of delivery. The Employer allows the possibility of delivery of the subject of the contract with a shelf life of less than 12 months only if the Contractor obtains the written consent of the Employer.